Plain-English translation of NCT07118098 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is looking for people who may be at risk of developing type 1 diabetes before they show any symptoms. Researchers will take a small blood sample and test it for special markers called autoantibodies that signal the early stages of type 1 diabetes. If you have a family member or close friend who has been diagnosed with type 1 diabetes, you may be eligible to participate.
Type 1 diabetes can take years to develop after warning signs first appear in the blood. By catching these early markers, doctors hope to identify people at risk and potentially intervene before serious symptoms develop, which could help prevent or delay the disease.
You likely qualify if…
You likely don't qualify if…
If you qualify, a member of the research team will ask you to provide a small blood sample, which will be tested for autoantibodies. If your results are negative (no autoantibodies found), you will not need further testing. If your results are positive (one or more autoantibodies detected), the clinical team will contact you to discuss next steps and arrange follow-up care.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Belgium
France
Italy
Poland
Slovenia
INNODIA iVZW
Enrollment target
~30,000 participants
Started
June 2025
Primary completion
December 2027
Age range
1 Year – 45 Years
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Laura Moreno Belmonte
INNODIA iVZW
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.